Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

PASER

AMINOSALICYLIC ACID

Standard Dose
4GM/PACKET
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview PASER is listed in Drugs@FDA under application 074346 (ANDA).

Marketing status: Prescription Active ingredient AMINOSALICYLIC ACID Form and strength GRANULE, DELAYED RELEASE;ORAL - 4GM/PACKET Sponsor ADAPTIS Submission history Latest submission status date: 1996-08-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview PASER is listed in Drugs@FDA under application 074346 (ANDA). Marketing status: Prescription Active ingredient AMINOSALICYLIC ACID Form and strength GRANULE, DELAYED RELEASE;ORAL - 4GM/PACKET Sponsor ADAPTIS Submission history Latest submission status date: 1996-08-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
PASER (AMINOSALICYLIC ACID) | Drug Monograph | MedicHelpline